In this webinar, you’ll discover the principles of antibody panel design as well as how to streamline the process to amplify the quality of your results.

Join us on April 16 as we explore pioneering salts and polymorphs shaping the future of psychedelic therapeutics with expert speaker, Dr. Sam Clark, CEO and Founder of Terran Biosciences.

This presentation will focus on the shift towards hydrogen as a carrier gas in Gas Chromatography-Mass Spectrometry (GC-MS), motivated by helium's scarcity and high cost. It will discuss the benefits of hydrogen and address challenges like safety and the impact on analytical accuracy.

Cell-to-cell communication in cancer is pivotal for tumor progression, metastasis, and treatment resistance. This complex network of signalling pathways allows cancer cells to interact, shaping their behavior and response to therapy.

Biotherapeutic drugs are complex and can perform their function through interactions with more than one target molecule. During development and quality control, a range of analytical technologies are used to characterize biotherapeutic drugs in terms of their structural integrity and activity. Ligand-binding assays are relevant for characterization and quantitation of the functional drug, however current analytical approaches may no longer be sufficient for analysis of emerging drug modalities.
Biacore™ assays are based on ligand binding and used in development and characterization of drug product using active concentration measurements, target binding, potency (E50)
and Fc receptor (FcR) analysis.

This webinar explores a highly sensitive, automated assay workflow to provide high-quality results for low-abundance biomarkers in serum, plasma and cerebrospinal fluid.